Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease; Dementia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01227564
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 63
Testing effectiveness (Phase 2)Study completedNCT00857506
What this trial is testing

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 152
Post-approval studies (Phase 4)Study completedNCT02190084
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia

Who this might be right for
ApathyAlzheimer's Dementia
Central Arkansas Veterans Healthcare System 20
Post-approval studies (Phase 4)Study completedNCT00216515
What this trial is testing

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Janssen Korea, Ltd., Korea 102
Large-scale testing (Phase 3)UnknownNCT00715858
What this trial is testing

A Pilot Study of Inflammatory Markers in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
McMaster University 21
Large-scale testing (Phase 3)Looking for participantsNCT07066826
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD 720
Testing effectiveness (Phase 2)Study completedNCT01764243
What this trial is testing

Safety and Efficacy of MT-4666

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 450
Not applicableNot Yet RecruitingNCT07376135
What this trial is testing

LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment.

Who this might be right for
Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Medical University of Vienna 300
Not applicableStudy completedNCT05784298
What this trial is testing

Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Dementia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 27
Not applicableUnknownNCT05251649
What this trial is testing

Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chinese PLA General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00574132
What this trial is testing

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,331
Very early researchStudy completedNCT01729598
What this trial is testing

Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study

Who this might be right for
Alzheimer's Disease
Gregory Jicha, 323-5550 14
Not applicableUnknownNCT03811184
What this trial is testing

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

Who this might be right for
Cognitive ImpairmentAlzheimer Disease
MemScreen 400
Testing effectiveness (Phase 2)Ended earlyNCT03639987
What this trial is testing

Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

Who this might be right for
Cognitive DysfunctionAlzheimer's Disease
Biogen 52
Not applicableLooking for participantsNCT05980052
What this trial is testing

Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Who this might be right for
Physical ActivityExercise
Arizona State University 144
Not applicableUnknownNCT05655793
What this trial is testing

The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis

Who this might be right for
Alzheimer Disease
Maastricht University Medical Center 200
Not applicableUnknownNCT03827733
What this trial is testing

Gut Microbiota and Alzheimer's Diseases

Who this might be right for
Alzheimer Disease
Shanghai 10th People's Hospital 200
Not applicableStudy completedNCT02050464
What this trial is testing

Computational Tools for Early Diagnosis of Memory Disorders

Who this might be right for
Alzheimer DiseaseFrontotemporal DementiaDementia, Vascular+1 more
University of Eastern Finland 126
Not applicableEnded earlyNCT01689948
What this trial is testing

Alzheimer Disease : Rehabilitation's Intervention at Home

Who this might be right for
Alzheimer's Disease
Nantes University Hospital 17
Not applicableLooking for participantsNCT06088121
What this trial is testing

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Who this might be right for
Alzheimer's DiseaseDementiaBrain Diseases+5 more
Advanced Technology & Communications 180
Next Page